MDGL Prakiraan wutah bathi kanggo taun ngarep madrigalpharma.com

Lambang korporat lan logo Madrigal Pharmaceuticals, Inc. (MDGL)

The consensus earnings per share forecast vector reflects market expectations, where the 445.50 metric serves as the target level for Madrigal Pharmaceuticals (MDGL). Drug development is accelerating through AI-driven molecular screening while maintaining physician oversight. Revenues are based on the exclusive distribution of the drug Rezdiffra. First-mover status in the treatment of liver fibrosis provides Madrigal Pharmaceuticals (MDGL) with a robust moat against future competitors.

Madrigal Pharma (MDGL): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 16.11.2026

MDGL (Madrigal Pharmaceuticals Inc): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:MDGL, madrigalpharma.com
Produk dadi Madrigal Pharmaceuticals, Inc.

The expected growth in net income for the coming period is measured by the consensus EPS forecast, reflecting the potential for business margin expansion. This metric allows for an assessment of Madrigal Pharmaceuticals (MDGL) credit stability and the probability of a market valuation revision. By analyzing the target EPS growth rate for the next year, an investor gains a weighted assessment of profitability stripped of market noise. For Madrigal Pharmaceuticals (MDGL), this is critically important, as business viability currently depends on insurance coverage for the first MASH drug.

Analisis perusahaan pesaing

ASND (Ascendis) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep Corcept Therapeutics|Prakiraan wutah bathi kanggo taun ngarep RYTM|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AKRO (Akero Therapeutics, Inc.)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep metsera.com MTSR|MoonLake Corp (MLTX) - Prakiraan wutah bathi resik saben saham ing taun ngarep|CRNX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NAMS: Prakiraan wutah bathi resik saben saham kanggo taun ngarep|SLNO: Prakiraan wutah bathi kanggo taun ngarep|FOLD - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep 89bio Pharma|Agios Corp (AGIO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep structuretx.com (GPCR)|Prakiraan wutah bathi saben saham kanggo taun ngarep mimedx.com MDXG|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MBX: Prakiraan wutah bathi saben saham kanggo taun ngarep|Altimmune Corp - Proyeksi tambahing bathi saben saham ing taun ngarep|Aardvark Therapeutics Inc (AARD) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Biomea Fusion (BMEA)|Prakiraan wutah bathi kanggo taun ngarep QNCX|Proyeksi tambahing bathi saben saham ing taun ngarep GUTS|Prakiraan wutah bathi kanggo taun ngarep VTVT (vTv Therapeutics Inc.)|Dinamika bathi saben saham sing diarepake ing taun ngarep ATPC|Pluristem Therapeutics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep synlogictx.com SYBX|LPCN: Prakiraan wutah bathi kanggo taun ngarep|Matinas BioPharma Holdings, Inc. - Dinamika bathi saben saham sing diarepake ing taun ngarep|SPRB (Spruce Biosciences Inc.) - Prakiraan wutah bathi kanggo taun ngarep|galecto.com (GLTO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep organovo.com ONVO|Radius Health (RDUS) - Prakiraan wutah bathi resik saben saham ing taun ngarep